Dexamethasone conjugation to polyamidoamine dendrimers G1 and G2 for enhanced transfection efficiency with an anti-inflammatory effect

Journal of Drug Targeting

Volumn 20, Issue 8, 2012, Pages 667-677

  Young Kim, Jin ^a   Ryu, Jae Hwan ^a   Hyun, Hyesun ^a   Kim, Hyun Ah ^a   Sig Choi, Joon ^b   Yun Lee, Dong ^a   Rhim, Taiyoun ^a   Park, Jeong Hyun ^c   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

^b Chungnam National University   (South Korea)

^c Inje University   (South Korea)

Author keywords

Dexamethasone; Gene delivery; Polyamidoamine; Transfection; Tumor necrosis factor

Indexed keywords

DEXAMETHASONE 21 MESILATE; LIPOFECTAMINE; LIPOPOLYSACCHARIDE; PLASMID DNA; POLYAMIDOAMINE; POLYAMIDOAMINE PAMG1; POLYAMIDOAMINE PAMG2; POLYETHYLENEIMINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG EFFICACY; FLOW CYTOMETRY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; DENDRIMERS; DEXAMETHASONE; DNA; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEK293 CELLS; HUMANS; LIPIDS; MICE; PLASMIDS; POLYAMINES; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864602238     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.712127     Document Type: Article

References (33)

1. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. (1996). A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum Gene Ther, 7, 1947-1954.
2. Abes S, Moulton H, Turner J, Clair P, Richard JP, Iversen P, Gait MJ, Lebleu B. (2007). Peptide-based delivery of nucleic acids: Design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem Soc Trans, 35, 53-55.
3. Mi Bae Y, Choi H, Lee S, Ho Kang S, Tae Kim Y, Nam K, Sang Park J, Lee M, Sig Choi J. (2007). Dexamethasone-conjugated low molecular weight polyethylenimine as a nucleus-targeting lipopolymer gene carrier. Bioconjug Chem, 18, 2029-2036.
4. Chan CK, Jans DA. (2002). Using nuclear targeting signals to enhance non-viral gene transfer. Immunol Cell Biol, 80, 119-130.
5. Chauhan AS, Diwan PV, Jain NK, Tomalia DA. (2009). Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules, 10, 1195-1202.
6. Choi JS, Ko KS, Park JS, Kim YH, Kim SW, Lee M. (2006). Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm, 320, 171-178.
7. Choi JS, Nam K, Park JY, Kim JB, Lee JK, Park JS. (2004). Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release, 99, 445-456.
8. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T. (1999). A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res, 16, 1273-1279.
9. Godbey WT, Wu KK, Mikos AG. (2001). Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials, 22, 471-480.
10. Gruneich JA, Price A, Zhu J, Diamond SL. (2004). Cationic corticosteroid for nonviral gene delivery. Gene Ther, 11, 668-674.
11. Han S, Mahato RI, Sung YK, Kim SW. (2000). Development of biomaterials for gene therapy. Mol Ther, 2, 302-317.
12. Hébert E. (2003). Improvement of exogenous DNA nuclear importation by nuclear localization signal-bearing vectors: A promising way for non-viral gene therapy? Biol Cell, 95, 59-68.
13. Hyun H, Lee J, Hwang do W, Kim S, Hyun DK, Choi JS, Lee JK, Lee M. (2011). Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials, 32, 306-315.
14. Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. (2003). The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm, 252, 263-266.
15. Kang HC, Lee M, Bae YH. (2005). Polymeric gene carriers. Crit Rev Eukaryot Gene Expr, 15, 317-342.
16. Kim H, Bae YM, Kim HA, Hyun H, Yu GS, Choi JS, Lee M. (2010). Synthesis and characterization of dexamethasone-conjugated linear polyethylenimine as a gene carrier. J Cell Biochem, 110, 743-751.
17. Kim H, Kim HA, Bae YM, Choi JS, Lee M. (2009a). Dexamethasoneconjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes. J Gene Med, 11, 515-522.
18. Kim H, Kim HA, Choi JS, Lee M. (2009b). Delivery of hypoxia inducible heme oxygenase-1 gene using dexamethasone cojugated polyethylenimine for protection of cardiomyocytes under hypoxia. Bull Korean Chem Soc, 30, 897-901.
19. Kunath K, von Harpe A, Fischer D, Petersen H, Bickel U, Voigt K, Kissel T. (2003). Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecularweight polyethylenimine. J Control Release, 89, 113-125.
20. Lee M, Kim SW. (2002). Polymeric gene carriers. Pharm News, 9, 407-415.
21. Lee M, Kim SW. (2005). Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res, 22, 1-10.
22. Lemkine GF, Goula D, Becker N, Paleari L, Levi G, Demeneix BA. (1999). Optimisation of polyethylenimine-based gene delivery to mouse brain. J Drug Target, 7, 305-312.
23. Liu CC, Chien CH, Lin MT. (2000). Glucocorticoids reduce interleukin-1 concentration and result in neuroprotective effects in rat heatstroke. J Physiol (Lond), 527 Pt 2, 333-343.
24. Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. (1995). Transfection of folate-polylysine DNA complexes: Evidence for lysosomal delivery. Bioconjug Chem, 6, 512-515.
25. Niidome T, Huang L. (2002). Gene therapy progress and prospects: Nonviral vectors. Gene Ther, 9, 1647-1652.
26. Pietersz GA, Tang CK, Apostolopoulos V. (2006). Structure and design of polycationic carriers for gene delivery. Mini Rev Med Chem, 6, 1285-1298.
27. Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki K, Hayashida K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T, Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K. (2009). Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalintype prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest, 119, 1477-1488.
28. Tsurufuji S, Sugio K, Takemasa F. (1979). The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature, 280, 408-410.
29. Tuor UI, Simone CS, Barks JD, Post M. (1993). Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke, 24, 452-457.
30. Van der Aa MA, Koning GA, d'Oliveira C, Oosting RS, Wilschut KJ, Hennink WE, Crommelin DJ. (2005). An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems. J Gene Med, 7, 208-217.
31. Wu GY, Wu CH. (1988). Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry, 27, 887-892.
32. Yu VC, Näär AM, Rosenfeld MG. (1992). Transcriptional regulation by the nuclear receptor superfamily. Curr Opin Biotechnol, 3, 597-602.
33. Zausinger S, Westermaier T, Plesnila N, Steiger HJ, Schmid-Elsaesser R. (2003). Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: Comparison with customary therapeutic regimen. Stroke, 34, 1526-1532.